In this study we found that the inhibition of PARP1 resulted in increased PI3K/mTOR signaling, suggesting that SCLC may attempt to escape PARP inhibition by upregulation of the PI3K/mTOR pathway. The gene discussed is PARP1; the disease is small cell lung carcinoma.